Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates

Vanessa M. Beutgen,Aditya M. Bhagwat,Anna Mary Steitz,Silke Reinartz,Rolf Müller,Johannes Graumann
DOI: https://doi.org/10.1021/acs.analchem.3c04116
IF: 7.4
2024-05-31
Analytical Chemistry
Abstract:Virus inactivation is a prerequisite for safe handling of high-risk infectious samples. β-Propiolactone (BPL) is an established reagent with proven virucidal efficacy. BPL primarily reacts with DNA, RNA, and amino acids. The latter may modify antigenic protein epitopes interfering with binding properties of affinity reagents such as antibodies and aptamers used in affinity proteomic screens. We investigated (i) the impact of BPL treatment on the analysis of protein levels in plasma samples using...
chemistry, analytical
What problem does this paper attempt to address?